BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8079372)

  • 1. In vitro neutralization of the inhibitory effect of Microcystin-LR to protein phosphatase 2A by antibody against the toxin.
    Lin JR; Chu FS
    Toxicon; 1994 May; 32(5):605-13. PubMed ID: 8079372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases.
    Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE
    Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of an archaeal protein phosphatase activity by okadaic acid, microcystin-LR, or calyculin A.
    Oxenrider KA; Rasche ME; Thorsteinsson MV; Kennelly PJ
    FEBS Lett; 1993 Oct; 331(3):291-5. PubMed ID: 8397116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyanobacterial microcystin-LR is a potent and specific inhibitor of protein phosphatases 1 and 2A from both mammals and higher plants.
    MacKintosh C; Beattie KA; Klumpp S; Cohen P; Codd GA
    FEBS Lett; 1990 May; 264(2):187-92. PubMed ID: 2162782
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein.
    Kloeker S; Reed R; McConnell JL; Chang D; Tran K; Westphal RS; Law BK; Colbran RJ; Kamoun M; Campbell KS; Wadzinski BE
    Protein Expr Purif; 2003 Sep; 31(1):19-33. PubMed ID: 12963337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged sublethal exposure to the protein phosphatase inhibitor microcystin-LR results in multiple dose-dependent hepatotoxic effects.
    Solter PF; Wollenberg GK; Huang X; Chu FS; Runnegar MT
    Toxicol Sci; 1998 Jul; 44(1):87-96. PubMed ID: 9720145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein.
    Takai A; Sasaki K; Nagai H; Mieskes G; Isobe M; Isono K; Yasumoto T
    Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):657-65. PubMed ID: 7702557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A.
    Runnegar M; Berndt N; Kong SM; Lee EY; Zhang L
    Biochem Biophys Res Commun; 1995 Nov; 216(1):162-9. PubMed ID: 7488083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcystin-LR and okadaic acid-induced cellular effects: a dualistic response.
    Gehringer MM
    FEBS Lett; 2004 Jan; 557(1-3):1-8. PubMed ID: 14741332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Okadaic acid and microcystin-LR directly inhibit the methylation of protein phosphatase 2A by its specific methyltransferase.
    Li M; Damuni Z
    Biochem Biophys Res Commun; 1994 Jul; 202(2):1023-30. PubMed ID: 8048914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocyte DNA replication is abolished by inhibitors selecting protein phosphatase 2A rather than phosphatase 1.
    Mellgren G; Vintermyr OK; Bøe R; Døskeland SO
    Exp Cell Res; 1993 Apr; 205(2):293-301. PubMed ID: 8387016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of microcystin-LR, a potent inhibitor of type 1 and type 2A protein phosphatases.
    Honkanen RE; Zwiller J; Moore RE; Daily SL; Khatra BS; Dukelow M; Boynton AL
    J Biol Chem; 1990 Nov; 265(32):19401-4. PubMed ID: 2174036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular basis for different interactions of marine toxins with protein phosphatase-1. Molecular models for bound motuporin, microcystins, okadaic acid, and calyculin A.
    Bagu JR; Sykes BD; Craig MM; Holmes CF
    J Biol Chem; 1997 Feb; 272(8):5087-97. PubMed ID: 9030574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein phosphatase inhibition and in vivo hepatotoxicity of microcystins.
    Runnegar MT; Kong S; Berndt N
    Am J Physiol; 1993 Aug; 265(2 Pt 1):G224-30. PubMed ID: 8396333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential toxicity of the protein phosphatase inhibitors microcystin and calyculin A.
    Runnegar MT; Maddatu T; Deleve LD; Berndt N; Govindarajan S
    J Pharmacol Exp Ther; 1995 Apr; 273(1):545-53. PubMed ID: 7714810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of phosphate from phosphohistidine in proteins.
    Kim Y; Pesis KH; Matthews HR
    Biochim Biophys Acta; 1995 Aug; 1268(2):221-8. PubMed ID: 7662712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of microcystin-protein phosphatase adduct formation with immunochemical methods.
    Liu BH; Yu FY; Huang X; Chu FS
    Toxicon; 2000 May; 38(5):619-32. PubMed ID: 10673155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucrose-phosphate synthase is dephosphorylated by protein phosphatase 2A in spinach leaves. Evidence from the effects of okadaic acid and microcystin.
    Siegl G; MacKintosh C; Stitt M
    FEBS Lett; 1990 Sep; 270(1-2):198-202. PubMed ID: 2171989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microcystin uptake and inhibition of protein phosphatases: effects of chemoprotectants and self-inhibition in relation to known hepatic transporters.
    Runnegar M; Berndt N; Kaplowitz N
    Toxicol Appl Pharmacol; 1995 Oct; 134(2):264-72. PubMed ID: 7570603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of serine/threonine protein phosphatases in RINm5F insulinoma cells.
    Sjöholm A; Honkanen RE; Berggren PO
    Biosci Rep; 1993 Dec; 13(6):349-58. PubMed ID: 8204804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.